Physician profile
Megan Schmidt
NPI 1912326992
$1,754.93
in general payments reported to CMS, 2019-2025
11 companies · $59.09 in 2025
The $59.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $1,320 · 2023: $79.64 · 2024: $194 · 2025: $59.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,215.08 | 2022 | |
| Gynesonics, INC. | $84.31 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $67.81 | 2021-2022 | |
| Hologic Sales and Service, LLC | $66.71 | 2022-2023 | Acessa Provu System |
| Astellas Pharma US INC | $62.45 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $60.41 | 2022-2025 | |
| Myovant Sciences INC. | $53.70 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $50.34 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $41.20 | 2024-2025 | Paragard T 380a |
| Applied Medical Resources Corporation | $31.09 | 2023 | Gelpoint V-Path |
| Evofem Biosciences, INC. | $21.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.